Latest Breaking News On - Biocon group - Page 1 : comparemela.com

Namma Metro plans to float tender for semi-naming rights

Namma Metro plans to float tender for semi-naming rights
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Biocon hebbagodiBiocon groupHebbagodi municipal corporationEmbassy groupInfosys foundationBangalore metro rail corporation limitedNaming rightElectronic cityYellow lineSampige road stationBettahalasur metro station

Biocon Q4 FY24 profit declines 57% y-o-y to ₹135 cr - The Hindu BusinessLine

Biocon Q4 FY24 profit declines 57% y-o-y to ₹135 cr - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Biocon biologicsKiran mazumdar shawZoho sridhar vembuVidushi nautiyalBiocon ltdBiocon groupBengaluru based bioconSridhar vembuExecutive chairperson

Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss - Eli Lilly and Co (NYSE:LLY), Bristol-Myers Squibb (NYSE:BMY)

Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D footprint, eyeing India as a pivotal hub for innovation and clinical trials.

United statesAndhra pradeshEli lillyBristol myers squibbDavid ricksBristol myers squibb coNovo nordiskChristopher boernerBristol myersBiocon group syngene internationalEli lilly and coBiocon groupSyngene international

Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025

The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference.

Andhra pradeshChristopher boernerBristol myersBiocon group syngene internationalBristol myers squibbBiocon groupUs drugmakerCancer cell therapiesCancer drugs

Bristol Myers CEO says India to have largest R&D presence outside US by 2025

Bristol Myers Squibb aims to expand its research and development presence in India and expects its newly inaugurated Hyderabad facility to become its largest unit outside the U.S. by 2025,.

Andhra pradeshJanane venkatramanChristopher boernerLeroy leoBristol myersRishika sadamBiocon group syngene internationalBristol myers squibbMyers squibbBiocon group